UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases

Annals of oncology, 2008-06, Vol.19 (6), p.1146-1153

2008

Volltextzugriff (PDF)

Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients

Annals of oncology, 2009-02, Vol.20 (2), p.272-277

2009

Volltextzugriff (PDF)

Body composition factor is independent prognosticator in advanced pancreatic cancer patients

Annals of oncology, 2018-10, Vol.29, p.viii617-viii617

2018

Volltextzugriff (PDF)

Phase III trial of adjuvant 5-fluorouracil and adriamycin versus 5-fluorouracil, adriamycin, and polyadenylic–polyuridylic acid (poly A:U) for locally advanced gastric cancer after curative surgery: final results of 15-year follow-up

Annals of oncology, 2008-03, Vol.19 (3), p.520-526

2008

Volltextzugriff (PDF)

External validation of nomogram for the prediction of recurrence after curative resection in early gastric cancer

Annals of oncology, 2012-02, Vol.23 (2), p.361-367

2012

Volltextzugriff (PDF)

Pemetrexed plus cisplatin in patients with previously treated advanced sarcoma: a multicenter, single-arm, phase II trial

ESMO open, 2021-10, Vol.6 (5), p.100249-100249, Article 100249

2021

Volltextzugriff (PDF)

Phase II study of combination chemotherapy of 5-fluorouracil, low-dose leucovorin, and oxaliplatin (FLOX regimen) in pretreated advanced gastric cancer

Annals of oncology, 2008-06, Vol.19 (6), p.1135-1140

2008

Volltextzugriff (PDF)

A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens

British journal of cancer, 2006-12, Vol.95 (12), p.1637-1641

2006

Volltextzugriff (PDF)

A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status

British journal of cancer, 2007-08, Vol.97 (4), p.458-463

2007

Volltextzugriff (PDF)

Treatment of advanced gastric cancer by palliative gastrectomy, cytoreductive therapy and postoperative intraperitoneal chemotherapy

British journal of surgery, 2002-04, Vol.89 (4), p.460-466

2002

Volltextzugriff (PDF)

Neoadjuvant chemotherapy with infusional 5-fluorouracil, adriamycin and cyclophosphamide (iFAC) in locally advanced breast cancer: an early response predicts good prognosis

Annals of oncology, 2005-11, Vol.16 (11), p.1778-1785

2005

Volltextzugriff (PDF)

A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)

ESMO open, 2024-09, Vol.9 (9), p.103668, Article 103668

2024

Volltextzugriff (PDF)

A Phase II Study of Infusional 5-Fluorouracil and Low-Dose Leucovorin with Docetaxel for Advanced Gastric Cancer

Oncology, 2006-01, Vol.70 (1), p.63-70

2006

Volltextzugriff (PDF)

Bilateral Breast Cancer: Differential Diagnosis Using Histological and Biological Parameters

Japanese journal of clinical oncology, 2007-07, Vol.37 (7), p.487-492

2007

Volltextzugriff (PDF)

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

The Lancet (British edition), 2010-08, Vol.376 (9742), p.687-697

2010

Volltextzugriff (PDF)

The Prognostic Nutritional Index Predicts Survival in Advanced Biliary Tract Cancer

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.e53-e53

2021

Volltextzugriff (PDF)

1729PBody composition factor is independent prognosticator in advanced pancreatic cancer patients

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

A novel anti-cancer compound development targeting YAP-TEAD protein-protein interaction

European journal of cancer (1990), 2022-10, Vol.174, p.S37-S37

2022

Volltextzugriff (PDF)

99P Circulating tumor DNA as a biomarker for neratinib and trastuzumab efficacy in HER2-mutated advanced solid tumors: Insights from KCSG AL20-17/KM23 phase II trial

Annals of oncology, 2024-09, Vol.35, p.S253-S254

2024

Volltextzugriff (PDF)

Different role of functional domains of hTR in DNA binding to telomere and telomerase reconstruction

FEBS letters, 2005-01, Vol.579 (1), p.127-132

2005

Volltextzugriff (PDF)

1413P Antibiotic administration and outcome of patients with advanced gastric cancer receiving programmed death-1 inhibitors or with single-agent chemotherapy

Annals of oncology, 2021-09, Vol.32, p.S1061-S1061

2021

Volltextzugriff (PDF)

Adjuvant 5-fluorouracil plus doxorubicin in D2-3 resected gastric carcinoma: 15-Year experience at a single institute

Cancer, 2001-06, Vol.91 (11), p.2016-2025

2001

Volltextzugriff (PDF)

Increased alternative lengthening of telomere phenotypes of telomerase-negative immortal cells upon trichostatin--a treatment

Anticancer research, 2013-03, Vol.33 (3), p.821-829

2013

Volltextzugriff (PDF)

Alteration of hTERT full-length variant expression level showed different gene expression profiles and genomic copy number changes in breast cancer

Oncology reports, 2006-04, Vol.15 (4), p.749-755

2006

Volltextzugriff (PDF)

Difference of interferon-α and interferon-β on melanoma growth and lymph node metastasis in mice

Melanoma research, 2013-04, Vol.23 (2), p.114-124

2013

Volltextzugriff (PDF)

1 – 25 von 145

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(138)
Mit Volltextzugriff
(136)

Publikationsform

Artikel
(142)
Tagungsberichte
(3)

Sprache

Englisch
(145)
Japanisch
(22)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases

Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients

Body composition factor is independent prognosticator in advanced pancreatic cancer patients

Phase III trial of adjuvant 5-fluorouracil and adriamycin versus 5-fluorouracil, adriamycin, and polyadenylic–polyuridylic acid (poly A:U) for locally advanced gastric cancer after curative surgery: final results of 15-year follow-up

External validation of nomogram for the prediction of recurrence after curative resection in early gastric cancer

Pemetrexed plus cisplatin in patients with previously treated advanced sarcoma: a multicenter, single-arm, phase II trial

Phase II study of combination chemotherapy of 5-fluorouracil, low-dose leucovorin, and oxaliplatin (FLOX regimen) in pretreated advanced gastric cancer

A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens

A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status

Treatment of advanced gastric cancer by palliative gastrectomy, cytoreductive therapy and postoperative intraperitoneal chemotherapy

Neoadjuvant chemotherapy with infusional 5-fluorouracil, adriamycin and cyclophosphamide (iFAC) in locally advanced breast cancer: an early response predicts good prognosis

A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)

A Phase II Study of Infusional 5-Fluorouracil and Low-Dose Leucovorin with Docetaxel for Advanced Gastric Cancer

Bilateral Breast Cancer: Differential Diagnosis Using Histological and Biological Parameters

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

The Prognostic Nutritional Index Predicts Survival in Advanced Biliary Tract Cancer

1729PBody composition factor is independent prognosticator in advanced pancreatic cancer patients

A novel anti-cancer compound development targeting YAP-TEAD protein-protein interaction

99P Circulating tumor DNA as a biomarker for neratinib and trastuzumab efficacy in HER2-mutated advanced solid tumors: Insights from KCSG AL20-17/KM23 phase II trial

Different role of functional domains of hTR in DNA binding to telomere and telomerase reconstruction

1413P Antibiotic administration and outcome of patients with advanced gastric cancer receiving programmed death-1 inhibitors or with single-agent chemotherapy

Adjuvant 5-fluorouracil plus doxorubicin in D2-3 resected gastric carcinoma: 15-Year experience at a single institute

Increased alternative lengthening of telomere phenotypes of telomerase-negative immortal cells upon trichostatin--a treatment

Alteration of hTERT full-length variant expression level showed different gene expression profiles and genomic copy number changes in breast cancer

Difference of interferon-α and interferon-β on melanoma growth and lymph node metastasis in mice

Suchergebnisse filtern